SereNeuro Therapeutics raises an undisclosed amount pre seed

◆ Announced

5 Oct 2026

◆ Company

◆ Source

◆ The Round

SereNeuro Therapeutics raised an undisclosed amount in pre seed funding, announced on 5 October 2026. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About SereNeuro Therapeutics

Preclinical-stage biotech developing non-opioid pain therapies using purified human pain-sensing neurons derived from induced pluripotent stem cells. SereNeuro Therapeutics is based in United States and currently at pre seed stage, operating in Biotech.

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links SereNeuro Therapeutics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market